By exploring the association between FAIM2 expression and multiple clinicopathological characteristics of NSCLC patients, we discovered that FAIM2 was an independent factor correlated with the tumor stage (P = 0.0024), lymph node metastasis (P = 0.0161), and bone metastasis (P = 0.0010) (Table 2). Here, FAIM2 is linked to neoplasm.